title: Effect of intermittent PTH(1-34) on human periodontal ligament cells transplanted into immunocompromised mice.
abstract: Residual periodontal ligament (PDL) cells in the damaged tissue are considered a prerequisite for a successful regeneration of the periodontal architecture with all its components, including gingiva, PDL, cementum, and bone. Among other approaches, current concepts in tissue engineering aim at a hormonal support of the regenerative capacity of PDL cells as well as at a supplementation of lost cells for regeneration. Here, we investigated how far an anabolic, intermittent parathyroid hormone (iPTH) administration would enhance the osteoblastic differentiation of PDL cells and the cellular ability to mineralize the extracellular matrix in an in vivo transplantation model. PDL cells were predifferentiated in a standard osteogenic medium for 3 weeks before subcutaneous transplantation into CD-1 nude mice using gelatin sponges as carrier. Daily injections of 40 μg/kg body weight PTH(1-34) or an equivalent dose of vehicle for 4 weeks were followed by explantation of the specimens and an immunohistochemical analysis of the osteoblastic marker proteins alkaline phosphatase (ALP), osteopontin, and osteocalcin. Signs of biomineralization were visualized by means of alizarin red staining. For verification of the systemic effect of iPTH application, blood serum levels of osteocalcin were determined. The osteogenic medium stimulated the expression of ALP and PTH1-receptor mRNA in the cultures. After transplantation, iPTH resulted in an increased cytoplasmic and extracellular immunoreactivity for all markers investigated. In contrast to only sporadic areas of mineralization under control conditions, several foci of mineralization were observed in the iPTH group. Blood serum levels of osteocalcin were elevated significantly with iPTH. These data indicate that the osteoblastic differentiation of human PDL cells and their ability for biomineralization can be positively influenced by iPTH in vivo. These findings hold out a promising prospect for the support of periodontal regeneration.
authors.affiliation: Department of Orthodontics, Dental Clinic, University of Bonn, Bonn, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Wolf
authors.forename: Stefan
authors.initials: S
authors.lastname: Lossdörfer
authors.forename: Nuersailike
authors.initials: N
authors.lastname: Abuduwali
authors.forename: Rainer
authors.initials: R
authors.lastname: Meyer
authors.forename: Sied
authors.initials: S
authors.lastname: Kebir
authors.forename: Werner
authors.initials: W
authors.lastname: Götz
authors.forename: Andreas
authors.initials: A
authors.lastname: Jäger
mesh_terms: D000293:Adolescent; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D002113:Calcification, Physiologic / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002648:Child; D003907:Dexamethasone / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects*; D007150:Immunohistochemistry; D051379:Mice; D008819:Mice, Nude; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D015675:Osteocalcin / Q000097:blood; D053495:Osteopontin / Q000378:metabolism; D010281:Parathyroid Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D010513:Periodontal Ligament / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology / Q000637:transplantation*; D054457:Tissue Scaffolds / Q000737:chemistry
chemical_list: D010281:Parathyroid Hormone; D015675:Osteocalcin; D053495:Osteopontin; D003907:Dexamethasone; D000469:Alkaline Phosphatase